The Question

If you live with migraine, you have probably been told you have one of two versions: episodic or chronic. The dividing line is a number. Have headache on 15 or more days a month, with at least 8 of those days being migraine, and you cross from "episodic" into "chronic" migraine. Stay below that line and you are "episodic."

That cutoff shapes a lot. It affects which treatments you can access, which clinical trials you qualify for, and how your condition is described in your medical record. But here is a fair question: does the body actually change at 15 days a month, or did we just pick a round number that felt convenient?

A new study published in The Journal of Headache and Pain set out to test exactly that. The researchers pooled data from more than 36,000 adults in population surveys across 14 countries and asked whether the evidence supports two separate conditions, or one condition that runs along a continuous range of attack frequency.

How Migraine Is Classified Now

The way we split migraine into "episodic" and "chronic" is more recent and more debated than most people realize. It comes from the International Classification of Headache Disorders, or ICHD, which is the rulebook headache specialists use for diagnosis.

The authors make a pointed observation: those frequency thresholds were carried forward into the current rulebook without strong empirical justification. In other words, the 15-day line has been treated as a hard biological border, but it was never really proven to be one. That is the gap this study tried to fill.

What the Study Did

This was a meta-analysis of individual participant data, which means the team combined the raw, person-level data from many surveys rather than just pooling published summary numbers. That approach lets researchers look at the whole distribution of attack frequency instead of pre-sorted groups.

The researchers diagnosed migraine using a consistent algorithm applied the same way to everyone, following the order set out in the headache classification. To make sure their conclusion was not an accident of who was included, they tested four different ways of defining the migraine group, including versions that added or removed people with probable medication-overuse headache. Then they looked at how headache features, quality of life, and lost days tracked against attack frequency.

What They Found

The central finding is about shape. If episodic and chronic migraine were truly different conditions, you would expect something to change abruptly at the dividing line. The data did not show that.

Burden climbed as attacks got more frequent, which fits common sense: more migraine days mean more disruption. But the rise was continuous. The disability did not suddenly multiply once someone passed 15 headache days. It accumulated step by step across the whole range. One nuance the authors noted is that lost household days appeared to level off after a point, suggesting there may be a ceiling to how many days can be lost rather than a sharp change tied to the chronic label.

Just as important, these patterns looked strikingly similar for men and women, and across all four ways the team defined the migraine group. That consistency is part of why the authors felt confident describing migraine as a single disorder expressed along a frequency spectrum.

What "Spectrum" Actually Means Here

Calling migraine a spectrum does not mean everyone experiences it the same way, and it does not mean frequency is unimportant. It means that attack frequency seems to vary along a smooth continuum rather than sorting people into two natural categories with a real biological border between them.

"Migraine, considered in relation to headache frequency, characteristics and attributed burden, is better understood as a spectrum disorder rather than as two entities distinguished categorically by frequency."

The practical implication the authors raise is for the next edition of the classification rulebook, ICHD-4, which is in development. If the 15-day line does not mark a true change in the underlying condition, then future definitions might describe migraine more by where someone sits on the frequency range than by which side of an arbitrary cutoff they fall on. That is a meaningful shift in how the field could think about diagnosis.

Why the 15-Day Line Still Matters in Practice

Here is the part worth holding onto, because it is easy to overshoot. Saying migraine is a spectrum does not erase the usefulness of the chronic migraine threshold in the real world. A cutoff can be clinically useful even if it is not a sharp biological boundary.

So the takeaway is not "the chronic label is meaningless." It is more subtle: the line is a practical administrative tool, not a wall between two diseases. People who sit just below the cutoff can be just as affected as people just above it, and this study is a reminder not to dismiss someone's burden simply because their numbers do not reach a particular threshold.

Limitations to Keep in Mind

This is strong, large-scale evidence, but it has real boundaries that the authors are upfront about.

It is also worth being clear about what the study does not claim. It does not say chronic migraine is not real, and it does not say high-frequency migraine is no more disabling than occasional attacks. Frequent attacks clearly carry more burden. The argument is narrower and specific: the burden grows gradually with frequency rather than snapping to a new level at one fixed point.

What This Means for You

If your attacks fall just short of the chronic migraine threshold, this research backs up something many people feel but struggle to get recognized: your migraine can be every bit as disabling as someone whose count is slightly higher. The number on a chart is a category, not a measure of how much you are suffering.

None of this changes your diagnosis or your treatment plan today. Current criteria still stand, and the chronic label still carries practical weight for access to certain therapies. But it is useful context for conversations with your clinician. If you are close to the line and your migraine is taking a heavy toll, that toll is worth treating seriously regardless of which side of 15 days you land on. Frequency is one part of the picture, and the burden you actually carry is another.

Key Takeaways

The headline is not that the chronic migraine label should disappear. It is that the line we draw is more of a practical convenience than a true biological border, and that people near the threshold deserve the same attention as those past it.